Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

A bioinformatics approach to the identification of hub genes of Huo Xin Pill (HXP) for the treatment of acute myocardial infarction

Qiang Yang¹, Juncan Ding¹, Ziyue Luo¹, Pengfei Hu²

¹The Second Clinical Medical College of Zhejiang Chinese Medical University; ²Department of Cardiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

For correspondence:- Pengfei Hu Email: 20064012@zcmu.edu.cn

Accepted: 27 November 2022 Published: 29 December 2022

Citation: Yang Q, Ding J, Luo Z, Hu P. A bioinformatics approach to the identification of hub genes of Huo Xin Pill (HXP) for the treatment of acute myocardial infarction. Trop J Pharm Res 2022; 21(12):2651-2658 doi: 10.4314/tjpr.v21i12.21

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To apply bioinformatics for the identification of potential genes associated with Huo Xin Pill (HXP), a traditional Chinese medicine (TCM) used for the treatment of acute myocardial infarction (AMI).

Methods: Mouse AMI expression profile dataset GSE153485 and HXP-treated mouse AMI expression profile dataset GSE147365 were downloaded from GEO database. Then, R software was used to screen differentially-expressed genes in AMI and differentially-expressed genes in HXP-treated AMI. Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses, Venn diagrams, and protein-protein interaction (PPI) analysis were carried out on the hub genes linked to the effect of HXP on AMI.

Results: Six hub genes were identified. Based on the differential analysis of the sham and AMI groups, GSE153485 and GSE147365 had 840 and 2116 differentially-expressed genes, respectively (p < 0.05). The GO and KEGG analyses revealed enrichments in actin filament organization, membrane repolarization, and regulation of the actin cytoskeleton. Differential analysis of the use of HXP on AMI showed that GSE147365 had 380 differentially-expressed genes, comprising 96 up-regulated genes and 284 down-regulated genes (p < 0.05). Thirteen potential acting target genes were obtained using a Venn diagram, while 6 key acting genes were obtained via final screening.

Conclusion: Six (6) hub genes linked to HXP and AMI have been identified using bioinformatics: Egr2, Tubb2a, Col4a2, Cnn2, Lmna, and Col4a1. This study provides a partial experimental basis for the use of HXP in the treatment of AMI. In addition, it provides new potential targets for the treatment of AMI.

Keywords: Huo Xin Pill, Acute myocardial infarction, Bioinformatics, Hub genes, Mechanistic studi